LUND, Sweden, Aug. 22, 2019 /PRNewswire/ — “We are executing according to plan. Our lead candidate BI-1206 has shown encouraging initial data in hematological cancers, and has now also entered clinical trials in solid cancer,” Martin Welschof, CEO BioInvent Financial informationSecond quarter 2019 Net sales SEK 32.9 (9.8) million....

YANTAI, China, Aug. 22, 2019 /PRNewswire/ — Newater Technology, Inc. (NASDAQ: NEWA) (“Newater,” “NEWA,” “we,” “our” or the “Company”), a developer, manufacturer and service provider of wastewater filtration products and engineered systems, today announced that its Annual General Meeting of shareholders (the “AGM”) will be held Wednesday, October 30, 2019...

STOCKHOLM, Aug. 22, 2019 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into an agreement to sell a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) to AstraZeneca for a total cash consideration of USD 95 M. A PRV entitles the holder to FDA priority...

MACAO, Aug. 22, 2019 /PRNewswire/ — Once a concept, AI is now ushering in a key stage of application. What’s the solution to the data silos among businesses? Given the enhanced regulation on data at home and abroad, what’s the solution to data privacy and security concerns? What’s the...

MACAO, Aug. 22, 2019 /PRNewswire/ — The 28th International Joint Conferences on Artificial Intelligence (IJCAI) was held from August 10th – 16th, in Macao, SAR, China. WeBank, the first private and digital bank in China, contributed to the event with multiple academic research findings, and demonstrated great engagement in IJCAI by...

CORK, Ireland, Aug. 22, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare’s cabotegravir for the treatment of HIV. The study achieved its primary...

BANGALORE, Indien, 22. August 2019 /PRNewswire/ — TECH5 hat MOSIP®1 erfolgreich mit seiner T5-ABIS2-Plattform und biometrischem SDK für Finger-, Iris- und Gesichtserkennung integriert. TECH-5 präsentierte dem Vorstand und der internationalen Beratergruppe3 von MOSIP am 6. August eine geprüfte und einsatzbereite Lösung mit eingebauter Biometrik. TECH5 ist der erste ABIS-Anbieter, der...

BANGALORE, Inde, 22 août 2019 /PRNewswire/ — TECH5 a intégré avec succès la plateforme MOSIP®1 avec sa plateforme T5-ABIS2 et ses kits de développement de logiciel (SDK) de biométrie pour la reconnaissance des empreintes digitales, de l’iris et du visage. TECH-5 a présenté une solution éprouvée et prête à...

– TECH5, primer vendedor ABIS que integra totalmente sus tecnologías biométricas con la plataforma de gestión de identidad MOSIP® BANGALORE, India, 22 de agosto de 2019 /PRNewswire/ — TECH5 ha integrado con éxito MOSIP®1 con su plataforma T5-ABIS2 y Biometric SDKs para reconocimiento dactilar, ocular y facial. TECH-5 presentó una solución...